sydrab

Suven Pharmaceuticals Ltd

Long
sydrab Updated   
NSE:SUVENPHAR   SUVEN PHARMACEUTICALS LTD
Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services
Small cap – Healthcare
Buy above 614 | Tgt 630, 642 | Sl 604
It is my view, to trade on your own analysis

Comment:
Both target achieved

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.